Virus Diagnostics and Antiviral Therapy in Acute Retinal Necrosis (ARN)

Acute retinal necrosis (ARN) is a fulminant necrotizing form of retinitis of viral origin. Without treatment, ARN leads to the irreversible blindness by destruction of the retina and the optic nerve. The clinical observation was first described under the term Kirisawa uveitis (Urayama et al., 1971) while the term acute retinal necrosis was introduced by Young & Bird (1978). The international diagnostic standard criteria were defined by Holland et al. (1994). ARN is a rare disease occurring world-wide in approximately one per 1.5-2.0 million persons per year (Muthiah et al., 2007; Vandercam et al., 2008). The rareness of this disease precludes randomized prospective clinical studies. Most observations are derived from small case series and homogenous international guidelines for therapy are still lacking. A few studies, however, allow statements on the causative agents and therapeutic principles.

[1]  J. Pokorná,et al.  [Acute retinal necrosis]. , 2012, Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti.

[2]  J. Duker,et al.  Treatment of acute retinal necrosis. , 2010, Ophthalmology.

[3]  S. Lightman,et al.  Antiviral selection in the management of acute retinal necrosis , 2009, Clinical ophthalmology.

[4]  U. Pleyer,et al.  Diagnostik und Differenzialdiagnostik bei akuter retinaler Nekrose , 2009, Der Ophthalmologe.

[5]  H. Fickenscher,et al.  [Acute retinal necrosis: Clinical features and therapy options]. , 2009, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[6]  H. Fickenscher,et al.  Akute retinale Nekrose aus Virologensicht , 2009, Der Ophthalmologe.

[7]  H. Fickenscher,et al.  Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. , 2009, Ophthalmology.

[8]  T. Brandt,et al.  Fewer Latent Herpes Simplex Virus Type 1 and Cytotoxic T Cells Occur in the Ophthalmic Division than in the Maxillary and Mandibular Divisions of the Human Trigeminal Ganglion and Nerve , 2009, Journal of Virology.

[9]  Rajiv Khanna,et al.  Immunobiology of Human Cytomegalovirus: from Bench to Bedside , 2009, Clinical Microbiology Reviews.

[10]  H. Fickenscher,et al.  [Acute retinal necrosis from the virologist's perspective]. , 2009, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[11]  S. Wechsler,et al.  Level of Herpes Simplex Virus Type 1 Latency Correlates with Severity of Corneal Scarring and Exhaustion of CD8+ T Cells in Trigeminal Ganglia of Latently Infected Mice , 2008, Journal of Virology.

[12]  T. Morio,et al.  Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis , 2008, Japanese Journal of Ophthalmology.

[13]  R. Hintzen,et al.  Herpetic encephalitis is a risk factor for acute retinal necrosis , 2008, Neurology.

[14]  C. Baty,et al.  Noncytotoxic Lytic Granule–Mediated CD8+ T Cell Inhibition of HSV-1 Reactivation from Neuronal Latency , 2008, Science.

[15]  H. Goto,et al.  Acute retinal necrosis in Japan. , 2008, Ophthalmology.

[16]  S. Chou Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir , 2008, Reviews in medical virology.

[17]  P. le Hoang,et al.  Comparison of Immunoblotting, Calculation of the Goldmann-Witmer Coefficient, and Real-Time PCR Using Aqueous Humor Samples for Diagnosis of Ocular Toxoplasmosis , 2008, Journal of Clinical Microbiology.

[18]  J. Sinclair Human cytomegalovirus: Latency and reactivation in the myeloid lineage. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  H. Fickenscher,et al.  [Atypical ocular toxoplasmosis with concomitant ocular reactivation of varicella-zoster virus and cytomegalovirus in an immunocompromised host]. , 2008, Klinische Monatsblatter fur Augenheilkunde.

[20]  D. Fish,et al.  Vitreous penetration of orally administered valacyclovir. , 2007, American journal of ophthalmology.

[21]  D. Fish,et al.  Vitreous penetration of orally administered famciclovir. , 2008, American journal of ophthalmology.

[22]  I. Tajunisah,et al.  Acute retinal necrosis by cytomegalovirus in an immunocompetent adult: case report and review of the literature , 2009, International Ophthalmology.

[23]  S. Bertrais,et al.  Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  P. Kennedy,et al.  The neurotropic herpes viruses: herpes simplex and varicella-zoster , 2007, The Lancet Neurology.

[25]  B. Schmidt,et al.  Impaired Plasmacytoid Dendritic Cell Innate Immune Responses in Patients with Herpes Virus-Associated Acute Retinal Necrosis1 , 2007, The Journal of Immunology.

[26]  M. Michaelides,et al.  Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK , 2007, British Journal of Ophthalmology.

[27]  T. Missotten,et al.  Acute Retinal Necrosis: Features, Management, and Outcomes , 2007 .

[28]  Takeshi Nakao,et al.  Acute retinal necrosis following herpes simplex encephalitis. , 2007, Archives of neurology.

[29]  S. Elner,et al.  Treatment of acute retinal necrosis syndrome with oral antiviral medications. , 2005, Ophthalmology.

[30]  M. Cordero-Coma,et al.  Herpetic retinitis. , 2007, Herpes : the journal of the IHMF.

[31]  M. Mochizuki,et al.  Epidemiological Survey of Intraocular Inflammation in Japan , 2007, Japanese Journal of Ophthalmology.

[32]  David J. Wilson,et al.  Primary treatment of acute retinal necrosis with oral antiviral therapy. , 2006, Ophthalmology.

[33]  K. Biron Antiviral drugs for cytomegalovirus diseases. , 2006, Antiviral research.

[34]  P. Wolkenstein,et al.  A survey on the prevalence of orofacial herpes in France: the INSTANT Study. , 2006, Journal of the American Academy of Dermatology.

[35]  G. Amidon,et al.  Stability of valacyclovir: implications for its oral bioavailability. , 2006, International journal of pharmaceutics.

[36]  R. Pandit,et al.  Unilateral Recurrent Acute Retinal Necrosis Syndrome Caused by Cytomegalovirus in an Immune-Competent Adult , 2006, European journal of ophthalmology.

[37]  E. Bristow,et al.  Bilateral acute retinal necrosis syndrome following herpes simplex type 1 encephalitis , 2006, Eye.

[38]  M. Tamai,et al.  A comparative study of the polymerase chain reaction and local antibody production in acute retinal necrosis syndrome and cytomegalovirus retinitis , 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.

[39]  A. Rothova,et al.  Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis , 1989, International Ophthalmology.

[40]  E. Clercq,et al.  Acyclic nucleoside phosphonates: a key class of antiviral drugs , 2005, Nature Reviews Drug Discovery.

[41]  A. Mitra,et al.  Identification and Characterization of a Na+-Dependent Neutral Amino Acid Transporter, ASCT1, in Rabbit Corneal Epithelial Cell Culture and Rabbit Cornea , 2005, Current eye research.

[42]  Risto S. Cvetković,et al.  Valganciclovir , 2012, Drugs.

[43]  F. Rozenberg,et al.  Necrotising retinopathies simulating acute retinal necrosis syndrome , 2004, British Journal of Ophthalmology.

[44]  S. Tyring,et al.  Recent Clinical Experience with Famciclovir — A ‘Third Generation’ Nucleoside Prodrug , 2004, Antiviral chemistry & chemotherapy.

[45]  K. Khanna,et al.  Immune control of herpes simplex virus during latency. , 2004, Current opinion in immunology.

[46]  D. Stanescu,et al.  Clinical characteristics of acute HSV-2 retinal necrosis. , 2004, American journal of ophthalmology.

[47]  P. Murray,et al.  Oral valganciclovir treatment of varicella zoster virus acute retinal necrosis , 2004, Eye.

[48]  B. Alexander,et al.  Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[49]  C. Lowder,et al.  Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. , 2004, Ophthalmology.

[50]  E. De Clercq Antiviral drugs in current clinical use. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[51]  T. Brandt,et al.  Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. , 2003, The American journal of pathology.

[52]  W. Sadee,et al.  Intra- and Interindividual Variabilities of Valacyclovir Oral Bioavailability and Effect of Coadministration of an hPEPT1 Inhibitor , 2003, Antimicrobial Agents and Chemotherapy.

[53]  F. Rozenberg,et al.  Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis , 2003, The British journal of ophthalmology.

[54]  C. Barry,et al.  Herpetic Encephalitis and Acute Retinal Necrosis , 2002 .

[55]  P. Gain,et al.  Herpes simplex virus type 1 encephalitis associated with acute retinal necrosis syndrome in an immunocompetent patient. , 2002, Acta ophthalmologica Scandinavica.

[56]  I. Scott,et al.  Intravitreal antivirals in the management of patients with acquired immunodeficiency syndrome with progressive outer retinal necrosis. , 2002, Archives of ophthalmology.

[57]  S Hercberg,et al.  Seroprevalence of HSV-1 and HSV-2 infection in the general French population , 2002, Sexually transmitted infections.

[58]  Changkook Kim,et al.  Unilateral acute retinal necrosis occurring 2 years after herpes simplex type 1 encephalitis. , 2002, Ophthalmic surgery and lasers.

[59]  M. Wills,et al.  Latency and reactivation of human cytomegalovirus. , 2002, The Journal of infection.

[60]  H. Zambarakji,et al.  Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy , 2002, Ocular immunology and inflammation.

[61]  E. Cunningham,et al.  Herpes simplex virus type 1 associated acute retinal necrosis following encephalitis. , 2001, Retina.

[62]  T. James,et al.  Viral causes of the acute retinal necrosis syndrome , 2001, Current opinion in ophthalmology.

[63]  J. Greenwood,et al.  Bilateral acute retinal necrosis and herpes simplex type 2 encephalitis in a neonate , 2001, The British journal of ophthalmology.

[64]  H. Kaplan,et al.  Herpes simplex virus type 2 as a cause of acute retinal necrosis syndrome in young patients. , 2001, Ophthalmology.

[65]  C. Chan,et al.  High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis. , 2001, American journal of ophthalmology.

[66]  T. Liesegang Herpes Simplex Virus Epidemiology and Ocular Importance , 2001, Cornea.

[67]  A. Osterhaus,et al.  Herpes simplex virus type 1 (HSV‐1)–induced retinitis following herpes simplex encephalitis: Indications for brain‐to‐eye transmission of HSV‐1 , 2000, Annals of neurology.

[68]  H. Offret,et al.  Neuronal pathways for the propagation of herpes simplex virus type 1 from one retina to the other in a murine model. , 2000, The Journal of general virology.

[69]  Y. Imai,et al.  High prevalence of herpes simplex virus type 2 in acute retinal necrosis syndrome associated with herpes simplex virus in Japan. , 2000, American journal of ophthalmology.

[70]  T. Cihlar,et al.  Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.

[71]  P. Lebon,et al.  Neurological Complications of Varicella-zoster Virus Infection in Adults with Human Immunodeficiency Virus Infection , 2000, Scandinavian journal of infectious diseases.

[72]  J. Smialek,et al.  Quantitation of Latent Varicella-Zoster Virus and Herpes Simplex Virus Genomes in Human Trigeminal Ganglia , 1999, Journal of Virology.

[73]  M. Bruinenberg,et al.  Increased presence of Epstein–Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis , 1998, The British journal of ophthalmology.

[74]  T. Margolis,et al.  Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis. Use in diagnostic dilemmas. , 1998, Ophthalmology.

[75]  J. Sakai,et al.  [A study of 44 patients with Kirisawa type uveitis]. , 1997, Nippon Ganka Gakkai zasshi.

[76]  P. McCluskey,et al.  Delayed acute retinal necrosis after herpetic encephalitis , 1997, The British journal of ophthalmology.

[77]  T. Margolis,et al.  Cytomegalovirus-associated acute retinal necrosis syndrome. , 1997, American journal of ophthalmology.

[78]  M. Figueroa,et al.  Famciclovir for the treatment of acute retinal necrosis (ARN) syndrome. , 1997, American journal of ophthalmology.

[79]  M. Bruinenberg,et al.  Twenty years' delay of fellow eye involvement in herpes simplex virus type 2-associated bilateral acute retinal necrosis syndrome. , 1996, American journal of ophthalmology.

[80]  W. Freeman,et al.  Clinicopathologic correlations in acute retinal necrosis caused by herpes simplex virus type 2. , 1996, Archives of ophthalmology.

[81]  P T de Jong,et al.  Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. , 1996, American journal of ophthalmology.

[82]  W. Quint,et al.  Diagnostic assays in cytomegalovirus retinitis: detection of herpesvirus by simultaneous application of the polymerase chain reaction and local antibody analysis on ocular fluid. , 1996, The British journal of ophthalmology.

[83]  P. Rolan,et al.  Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans , 1995, Antimicrobial agents and chemotherapy.

[84]  L. Morse,et al.  Diagnosis and management of viral retinitis in the acute retinal necrosis syndrome. , 1995, Seminars in ophthalmology.

[85]  D. Thorley-Lawson,et al.  A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.

[86]  G. Holland Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. , 1994, American journal of ophthalmology.

[87]  P T de Jong,et al.  Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. , 1994, American journal of ophthalmology.

[88]  R. Brockhurst,et al.  Delayed onset of bilateral acute retinal necrosis syndrome: a 34-year interval. , 1993, Annals of ophthalmology.

[89]  W. Culbertson,et al.  Acute Retinal Necrosis and Similar Retinitis Syndromes , 1993, International ophthalmology clinics.

[90]  G. Naumann,et al.  Detection of varicella zoster virus DNA and viral antigen in the late stage of bilateral acute retinal necrosis syndrome. , 1992, Archives of ophthalmology.

[91]  W. Culbertson,et al.  Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. , 1992, American journal of ophthalmology.

[92]  D. Jabs,et al.  Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. , 1991, American journal of ophthalmology.

[93]  J. Duker,et al.  Diagnosis and management of the acute retinal necrosis (ARN) syndrome. , 1991, Survey of ophthalmology.

[94]  T. Matsuo,et al.  HLA-DR9 associated with the severity of acute retinal necrosis syndrome. , 1991, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[95]  P. Dugel,et al.  Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. , 1990, American journal of ophthalmology.

[96]  A. Rothova,et al.  New developments in the analysis of local antibody production , 1990 .

[97]  W. Culbertson,et al.  An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. , 1989, American journal of ophthalmology.

[98]  D. Campoli-Richards,et al.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. , 1989, Drugs.

[99]  M. D. Topal,et al.  Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. , 1988, The Journal of biological chemistry.

[100]  L. Corey,et al.  Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. , 1987, The New England journal of medicine.

[101]  E. Dussaix,et al.  New approaches to the detection of locally produced antiviral antibodies in the aqueous of patients with endogenous uveitis. , 1987, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[102]  M. Blumenkranz,et al.  Varicella zoster virus is a cause of the acute retinal necrosis syndrome. , 1986, Ophthalmology.

[103]  M. Blumenkranz,et al.  Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. , 1986, Ophthalmology.

[104]  B. Bean,et al.  Evaluation of Oral Acyclovir Therapy , 1985, Drug intelligence & clinical pharmacy.

[105]  M. Paavola,et al.  Bilateral acute retinal necrosis. , 1982, American journal of ophthalmology.

[106]  J. Dry Acyclovir , 1981, The Lancet.

[107]  F. Price,et al.  Bilateral acute retinal necrosis. , 1980, American journal of ophthalmology.

[108]  J W DUGGAN,et al.  Herpes simplex virus. , 1961, Transactions of the Canadian Ophthalmological Society.

[109]  H. Goldmann,et al.  Antikörper im Kammerwasser , 1954 .

[110]  H. Goldmann,et al.  [Antibodies in the aqueous humor]. , 1954, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.